Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Approvals
Rapamune, Pfizer (PFE)'s Branding-Troubled Drug, Gets FDA Approval for Rare Lung Disease 5/29/2015 7:44:21 AM
Actavis (ACT), Valeant (VRX) Win FDA Approval for VIBERZI to Treat IBS With Diarrhea 5/28/2015 5:34:07 AM
MYOS (MYOS) Receives Health Canada Approval Of Proprietary Ingredient Fortetropin 5/28/2015 10:49:04 AM
Boehringer Ingelheim Release: Type 2 Diabetes: Synjardy (Empagliflozin/Metformin Hydrochloride) Approved In The European Union 5/28/2015 10:34:33 AM
Salix (SLXP) Announces FDA Approval of Xifaxan 550 mg For The Treatment Of IBS-D (Irritable Bowel Syndrome With Diarrhea) 5/28/2015 6:15:37 AM
Otsuka Pharmaceutical Co., Ltd.’s JINARC The First-Ever Treatment Approved In Europe For Adults Living With ADPKD, A Chronic Genetic Kidney Disease 5/27/2015 10:57:58 AM
Helsinn Group Release: The European Commission (EC) Approves ALOXI (palonosetron HCl) Injection To Prevent Nausea And Vomiting Due To Chemotherapy In Children As Young As One Month 5/27/2015 6:44:54 AM
Eli Lilly (LLY) Release: U.S. FDA Approves Humalog 200 units/mL KwikPen 5/27/2015 6:53:39 AM
Boehringer Ingelheim Grabs FDA Approval for Next-Gen COPD Drug 5/26/2015 8:16:50 AM
VentriPoint Diagnostics Wins Marketing Clearance From the FDA to Expand the Use of the VMS Heart Analysis System 5/26/2015 5:25:26 AM
Janssen Pharmaceuticals, Inc. Release: U.S. FDA Approves INVEGA TRINZA, First and Only Four-Times-A-Year Treatment For Schizophrenia 5/19/2015 6:31:10 AM
Baxter International (BAX) Receives U.S. FDA Approval for 0.9% Sodium Chloride Injection, USP From Sabinanigo, Spain, Facility For The U.S. Market 5/18/2015 11:39:09 AM
Pernix (PTX) Release: FDA Approves TREXIMET (Sumatriptan And Naproxen Sodium) For Use In Pediatric Patients 5/15/2015 9:21:44 AM
LabStyle Innovations Receives Health Canada Approval For Commercialization Of The Dario Diabetes Management Solution 5/14/2015 7:43:38 AM
Nova Laboratories Release: FDA Approves First Aseptically Spray Dried Biologic 5/14/2015 9:54:43 AM
1234567
//-->